QQQ

DIA

SPY

TLT

GLD

BTC/USD

QQQ

DIA

SPY

TLT

GLD

BTC/USD

Avis Budget

Barron's Most Recent Picks And Pans: Airbnb, Duke Energy, Evoqua, Netflix And More

Barron's Most Recent Picks And Pans: Airbnb, Duke Energy, Evoqua, Netflix And More

The cover story in this weekend's Barron's suggests how to play travel stocks as the recovery falters. Other featured articles discuss banking stocks with steady dividends, stocks that will benefit from share buybacks and why the boom in energy stocks may be over.

Jul 25, 2021, 6:31 PM

Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More

Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and an executive board chair were among the insiders buying shares this past week.

May 15, 2021, 1:39 PM

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

The Past Week's Notable Insider Buys: Agree Realty, Avis Budget, Zoetis And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week. Biotechs, REITs and a car rental leader saw notable insider purchasing of shares.

Feb 28, 2021, 8:36 AM

3 Reasons Why Avis Budget Shares Could Go Higher

3 Reasons Why Avis Budget Shares Could Go Higher

Shares of car rental company Avis Budget Group Inc. (NASDAQ: CAR) are up more than six-fold since bottoming at $6.35 last March and three catalysts could help lift shares even higher, according to BofA Securities.

Jan 25, 2021, 4:35 PM

Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More

Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More

Insider buying can be an encouraging signal for potential investors when markets face uncertainty. This past week, some insiders took advantage of biotech initial public offerings. Some insiders were making return trips to the buy window to increase their stakes.

Dec 12, 2020, 1:46 PM